ARCT vs AMGN: Which Stock is Better?

Side-by-side comparison of Arcturus Therapeutics Holdings Inc and Amgen Inc in 2026

Comparison Updated:

ARCT

Arcturus Therapeutics Holdings Inc

$6.39

AMGN

Amgen Inc

$361.13

Key Metrics Comparison

MetricARCTAMGNWinner
Market Cap$181.62M$197.43BAMGN
P/E RatioN/A25.70AMGN
EPS (TTM)$N/A$14.25AMGN
Revenue Growth-0.7%0.1%AMGN
Gross Margin-36.8%70.8%AMGN

Analyze ARCT

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARCT or AMGN a better investment?

Comparing ARCT and AMGN: Arcturus Therapeutics Holdings Inc has a market cap of $181.62M while Amgen Inc has $197.43B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARCT and AMGN?

ARCT (Arcturus Therapeutics Holdings Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARCT or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ARCT or AMGN?

AMGN has higher revenue growth at 0.1% vs -0.7% for ARCT.

Which company is more profitable: ARCT or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -36.8% for ARCT.

Which is the larger company: ARCT or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $197.43B compared to $181.62M for ARCT.

Should I buy ARCT or AMGN in 2026?

Both ARCT and AMGN have investment merit. ARCT trades at $6.39 while AMGN trades at $361.13. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARCT and AMGN stock?

Key differences: Market Cap ($181.62M vs $197.43B), P/E Ratio (N/A vs 25.7x), Revenue Growth (-0.7% vs 0.1%), Gross Margin (-36.8% vs 70.8%).

Popular Stock Comparisons